BioShares Biotechnology Selected Fundamentals

BioShares Biotechnology Products -- USA Etf  

USD 43.43  0.001  0.0023%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BioShares Biotechnology 
P/S 
 = 
MV Per Share 
Revenue Per Share 
 = 
5.6 times

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition
Based on latest financial disclosure the price to sales indicator of BioShares Biotechnology Products is roughly 5.6 times. This is 47.37% higher than that of the Bio Shares family, and 47.56% higher than that of Health category, The Price to Sales for all etfs is 677.78% lower than the firm.

BioShares Biotechnology Fundamental Drivers Relationships

BioShares Biotechnology Products is third largest ETF in price to earning as compared to similar ETFs. It is second largest ETF in price to sales as compared to similar ETFs fabricating about  0.31  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for BioShares Biotechnology Products is roughly  3.22 

Peer Comparison

BioShares Biotechnology Price to Sales Comparison
  Price to Sales 
      BioShares Biotechnology Comparables 
BioShares Biotechnology is currently under evaluation in price to sales as compared to similar ETFs.

Did you try this?

Run Price Ceiling Movement Now
   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
Hide  View All  NextLaunch Price Ceiling Movement

Asset Allocation

Fund Instrument Allocation for BioShares Biotechnology
The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
 Value 
      Instrument Type 

Fundamental Indicators

Current BioShares Biotechnology financial ratios